Dr. Aniket Saha
Claim this profileBI-LO Charities Children's Cancer Center
Expert in Cancer
Expert in Lymphoma
59 reported clinical trials
120 drugs studied
About Aniket Saha
Education:
- Earned an MD from St. George's University School of Medicine.
Experience:
- Pediatric Hematologist/Oncologist at BI-LO Charities Children's Cancer Center, Greenville, SC.
- Expertise in treating cancer and blood disorders in children.
- Collaborates with a multidisciplinary team at Greenville Health System.
- Affiliated with multiple hospitals in the Greenville area, including Greenville Memorial, Greer Memorial, Hillcrest Memorial, Laurens County Memorial, and Patewood Memorial Hospitals.
Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Lymphoma
Global LeaderPhiladelphia chromosome positive
BCR-ABL1 fusion positive
ABL-class fusion positive
Affiliated Hospitals
BI-LO Charities Children's Cancer Center
Prisma Health Cancer Institute - Eastside
Clinical Trials Aniket Saha is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Aniket Saha
Clinical Trial Related7 years of experience running clinical trials · Led 59 trials as a Principal Investigator · 25 Active Clinical TrialsTreatments Aniket Saha has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Methotrexate
- Vincristine Sulfate
- Doxorubicin Hydrochloride
Breakdown of trials Aniket Saha has run
Cancer
Lymphoma
Childhood Cancer
Benign Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aniket Saha specialize in?
Aniket Saha focuses on Cancer and Lymphoma. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage IV.
Is Aniket Saha currently recruiting for clinical trials?
Yes, Aniket Saha is currently recruiting for 23 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Aniket Saha has studied deeply?
Yes, Aniket Saha has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Aniket Saha?
Apply for one of the trials that Aniket Saha is conducting.
What is the office address of Aniket Saha?
The office of Aniket Saha is located at: BI-LO Charities Children's Cancer Center, Greenville, South Carolina 29605 United States. This is the address for their practice at the BI-LO Charities Children's Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.